SELECT LANGUAGE BELOW

Contending with China on trade to dominate US AI, quantum, and biotech industries

Contending with China on trade to dominate US AI, quantum, and biotech industries

China’s Supply Chain Leverage and U.S. Technological Challenges

Beijing has consistently demonstrated its willingness to use its supply chain advantages as a strategic tool. Recently, during a trip to Asia, President Trump had to address a rare earth dispute, revealing just a slice of the broader influence China holds over the U.S. economy, especially as we move toward new technologies.

Looking into the next decade, three technological domains stand out for their significance to American national security: artificial intelligence, quantum computing, and biotechnology. As China continues to sway U.S. manufacturing through rare earth materials, it’s a real concern that its influence in these critical sectors could dramatically increase.

America’s reliance on Chinese supply chains is already apparent. For instance, the U.S. leadership in AI hinges on data centers having access to specialized chemicals and essential hardware from China. Moreover, China controls crucial components for quantum computing, like cooling systems and precision lasers.

One of the more alarming discoveries recently pointed out that China is the only supplier of a vital ingredient in over a third of the roughly 2,000 medicines approved in the U.S., including amoxicillin, which is frequently prescribed.

Despite these challenges, the United States possesses powerful advantages. The private sector remains at the forefront globally in research and development expenditure, and its financial markets are robust and capable of backing ambitious projects. With skilled workers ranging from machine operators to tech researchers, the U.S. workforce is well-placed to rebuild critical supply chains.

However, realizing these benefits will require innovative incentives. A recent report outlines how to foster domestic production of vital inputs, especially for semiconductors and biotechnology. The U.S. government should encourage local manufacturing of necessary components, including those essential for the development of quantum computing and biotechnology.

To catalyze private investment in these areas, government action is critical. For instance, the Department of Defense could utilize its procurement powers to stimulate demand for advanced quantum computers that surpass current supercomputers. Additionally, supporting biomanufacturing initiatives could help small businesses bring new inventions to market by providing funding for shared infrastructure and simplifying the regulatory landscape.

While economic security begins domestically, the U.S. isn’t in this battle alone. Countries like the European Union, Japan, and South Korea have also committed to investments that could bolster U.S. manufacturing capabilities. When securing essential pharmaceutical ingredients and critical minerals, the U.S. should turn to dependable markets, as highlighted by a recent agreement with Australia to diversify sources for these materials.

It’s clear that the U.S. government can draw on a range of resources needed for today’s economic challenges and new technological competition. Nonetheless, many government departments work in silos, limiting their understanding of emerging risks. Establishing an Economic Security Center could enhance cooperation, improve technical knowledge, and strengthen ties with the private sector.

There is strong bipartisan momentum in support of strengthening critical supply chains and fostering innovation. It’s vital to build on this to ensure the American economy thrives in the evolving technological landscape.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News